This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Dong-A Pharm. Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Tae-Kyoung Sohn: Innovator in Benzamide Derivatives
Introduction
Tae-Kyoung Sohn is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his work on benzamide derivatives. His innovative approach has led to advancements in the treatment of various diseases associated with 5-HT receptors.
Latest Patents
Tae-Kyoung Sohn holds 1 patent for his invention related to benzamide derivatives. The patent describes a novel benzamide derivative or a pharmaceutically acceptable salt thereof, along with a method for preparing the same. This invention includes a 5-HT receptor agonist that demonstrates superior affinity for 5-HT receptors, a capability to reduce gastric emptying time, and low toxicity. Consequently, these derivatives are therapeutically effective for treating a variety of diseases linked to 5-HT receptors.
Career Highlights
Tae-Kyoung Sohn is currently associated with Dong-a Pharm. Co., Ltd., where he continues to contribute to pharmaceutical innovations. His work has been instrumental in developing new therapeutic options that enhance patient care and treatment outcomes.
Collaborations
He has collaborated with esteemed colleagues, including Soon-Hoe Kim and Weon-Bin Im, to further advance research and development in the pharmaceutical sector.
Conclusion
Tae-Kyoung Sohn's contributions to the field of pharmaceuticals, particularly through his work on benzamide derivatives, highlight his role as an innovator. His research not only advances scientific knowledge but also has the potential to improve therapeutic strategies for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile